QUICKLINKS AND VIEW OPITONS
Lorcaserin not approved by the FDA due to weight loss of only 3% and an increased cancer in rats
Saturday, October 23, 2010 9:01 am Email this article
The diet pill lorcaserin was not approved by the U.S. Food and Drug Administration (FDA) after an advisory panel voted 9-5 against recommending approval since weight loss was only 3 percent more than with a placebo and the drug was linked to cancer in rats.
The FDA notes that more studies are need to weigh the benefits versus risks. REFERENCE
Larkin C. Arena’s lorcaserin diet pill rejected by fda on concern over cancer risk. Bloomberg. 2010 Oct 23, 9:33 AM PT, http://www.bloomberg.com/news/2010-10-23/arena-s-lorcaserin-diet-pill-rejected-by-fda-on-concern-over-cancer-risk.html
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.